Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial. Issue 1 (31st December 2022)
- Record Type:
- Journal Article
- Title:
- Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial. Issue 1 (31st December 2022)
- Main Title:
- Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial
- Authors:
- Le Compte, Circe Gray
Lu, Shou-En
Ani, Julianne
McDougall, Jean
Walters, Scott T.
Toppmeyer, Deborah
Boyce, Tawny W.
Stroup, Antoinette
Paddock, Lisa
Grumet, Sherry
Lin, Yong
Heidt, Emily
Kinney, Anita Y. - Abstract:
- ABSTRACT: Background: National guidelines recommend cancer genetic risk assessment (CGRA) (i.e. genetic counseling prior to genetic testing) for women at increased risk for hereditary breast and ovarian cancer (HBOC). Less than one-half of eligible women obtain CGRA, leaving thousands of women and their family members without access to potentially life-saving cancer prevention interventions. Purpose: The Genetic Risk Assessment for Cancer Education and Empowerment Project (GRACE) addressed this translational gap, testing the efficacy of a tailored counseling and navigation (TCN) intervention vs. a targeted print brochure vs. usual care on CGRA intentions. Selected behavioral variables were theorized to mediate CGRA intentions. Methods: Breast and ovarian cancer survivors meeting criteria for guideline-based CGRA were recruited from three state cancer registries ( N = 654), completed a baseline survey, and were randomized. TCN and targeted print arms received the brochure; TCN also participated in a tailored, telephone-based decision coaching and navigation session grounded in the Extended Parallel Process Model and Ottawa Decision Support Framework. Participants completed a one-month assessment. Logistic regression was used to compare the rate of CGRA intentions. CGRA intentions and theorized mediator scores (continuous level variables) were calculated using mixed model analysis. Results: CGRA intentions increased for TCN (53.2%) vs. targeted print (26.7%) (OR = 3 .129; 95%ABSTRACT: Background: National guidelines recommend cancer genetic risk assessment (CGRA) (i.e. genetic counseling prior to genetic testing) for women at increased risk for hereditary breast and ovarian cancer (HBOC). Less than one-half of eligible women obtain CGRA, leaving thousands of women and their family members without access to potentially life-saving cancer prevention interventions. Purpose: The Genetic Risk Assessment for Cancer Education and Empowerment Project (GRACE) addressed this translational gap, testing the efficacy of a tailored counseling and navigation (TCN) intervention vs. a targeted print brochure vs. usual care on CGRA intentions. Selected behavioral variables were theorized to mediate CGRA intentions. Methods: Breast and ovarian cancer survivors meeting criteria for guideline-based CGRA were recruited from three state cancer registries ( N = 654), completed a baseline survey, and were randomized. TCN and targeted print arms received the brochure; TCN also participated in a tailored, telephone-based decision coaching and navigation session grounded in the Extended Parallel Process Model and Ottawa Decision Support Framework. Participants completed a one-month assessment. Logistic regression was used to compare the rate of CGRA intentions. CGRA intentions and theorized mediator scores (continuous level variables) were calculated using mixed model analysis. Results: CGRA intentions increased for TCN (53.2%) vs. targeted print (26.7%) (OR = 3 .129; 95% CI: 2.028, 4.827, p < .0001) and TCN vs. usual care (23.1%) (OR = 3 .778, CI: 2.422, 5.894, p < .0001). Perceived risk ( p = 0.023) and self-efficacy ( p = 0.035) mediated CGRA intentions in TCN. Conclusions: Improvements in CGRA intentions and theorized mediators support the use of a tailored communication intervention among women at increased HBOC risk. (Clinicaltrials.gov: NCT03326713.) Trial registration: ClinicalTrials.gov identifier: NCT03326713 . … (more)
- Is Part Of:
- Health psychology and behavioral medicine. Volume 10:Issue 1(2022)
- Journal:
- Health psychology and behavioral medicine
- Issue:
- Volume 10:Issue 1(2022)
- Issue Display:
- Volume 10, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 10
- Issue:
- 1
- Issue Sort Value:
- 2022-0010-0001-0000
- Page Start:
- 1190
- Page End:
- 1215
- Publication Date:
- 2022-12-31
- Subjects:
- Genetic testing -- genetic counseling -- cancer -- hereditary breast and ovarian cancer
Clinical health psychology -- Periodicals
Medicine and psychology -- Periodicals
613.09 - Journal URLs:
- http://www.tandfonline.com/ ↗
http://www.tandfonline.com/toc/rhpb20/current ↗ - DOI:
- 10.1080/21642850.2022.2150623 ↗
- Languages:
- English
- ISSNs:
- 2164-2850
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24676.xml